Determinants of Pterygium Occurrence and Recurrence in a Rural African Population
Launched by ANGURIA, PETER, M.D. · Jul 10, 2008
Trial Information
Current as of September 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Pterygium at least 1.5mm in extent
- • 2. Both male and female
- • 3. Age range 21-65 years
- • 4. Consenting to participate in study
- • 5. Unilateral and bilateral pterygium
- • 6. All grades of pterygium
- Exclusion Criteria:
- • 1. Previous cataract, corneoscleral and glaucoma surgery or corneoscleral trauma and corneolimbal scars
- • 2. Pseudopterygium or signs of malignancy on pterygium
- • 3. Recurrent pterygium
- • 4. Sufferers of collagen vascular disease, scleritis or diabetes -
About Anguria, Peter, M.D.
Dr. Peter Anguria, M.D., is a distinguished clinical trial sponsor renowned for his commitment to advancing medical research and improving patient outcomes. With extensive expertise in his field, Dr. Anguria leads innovative clinical studies that focus on developing novel therapies and treatment protocols. His research initiatives emphasize rigorous scientific methodology and ethical standards, ensuring the integrity and reliability of trial results. Through collaboration with multidisciplinary teams and healthcare institutions, Dr. Anguria aims to bridge the gap between laboratory discoveries and clinical applications, ultimately enhancing the quality of care for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Polokwane, Limpopo, South Africa
Patients applied
Trial Officials
Peter Anguria, MMed
Principal Investigator
Mankweng Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials